Fatal GvHD induced by PD-1 inhibitor pembrolizumab in a patient with Hodgkin's lymphoma (Q89291887)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

title

Fatal GvHD induced by PD-1 inhibitor pembrolizumab in a patient with Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

author name string

A K Singh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

L F Porrata

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

O Aljitawi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

L Shune

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

S Ganguly

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

J P McGuirk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

S Abhyankar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

publication date

25 April 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

1268-1270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease

2 April 2020

cites work

1 reference

12 December 2020

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

1 reference

12 December 2020

Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism

1 reference

12 December 2020

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

1 reference

12 December 2020

Nivolumab in a patient with refractory Hodgkin's lymphoma after allogeneic stem cell transplantation

1 reference

12 December 2020

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial

1 reference

12 December 2020

The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.

1 reference

12 December 2020

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

1 reference

12 December 2020

The blockade of immune checkpoints in cancer immunotherapy

1 reference

12 December 2020

Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.

1 reference

12 December 2020

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

1 reference

12 December 2020

Targeting the PD-1 pathway in patients with relapsed classic Hodgkin lymphoma following allogeneic stem cell transplant is safe and effective

1 reference

12 December 2020

PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies

1 reference

12 December 2020

Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality

1 reference

12 December 2020

PD-1 and its ligands in tolerance and immunity

1 reference

12 December 2020

The PDL1-PD1 Axis Converts Human T H 1 Cells into Regulatory T Cells

1 reference

12 December 2020

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2016.111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27111048 AND SRC:MED&resulttype=core&format=json

2 April 2020

1 reference